Figure 1D shows the protein levels of ARHGAP30 in subgroups of patients with LUAD, stratified based on sample type, individual cancer stage, ethnicity, sex, age, weight, tumor grade, and tumor histology (assessed using UALCAN [14] and CPTAC [15]). This evidence concerns the gene ARHGAP30 and cancer.